BioCentury
ARTICLE | Clinical News

DESyne BD Novolimus Eluting Coronary Stent System regulatory update

September 3, 2012 7:00 AM UTC

Elixir received CE Mark approval for its DESyne BD Novolimus Eluting Coronary Stent System to treat coronary artery disease (CAD). Elixir plans to launch the novolimus-eluting cobalt chromium alloy st...